MetaCap

Processa Pharmaceuticals Statistics

NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.56-0.13 (-7.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Processa Pharmaceuticals by the numbers

Processa Pharmaceuticals has a market capitalization of $4.4 million based on 2.80M shares outstanding. With trailing EPS of $-68.29, Processa Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.1% below its 50-day average and 31.3% below its 200-day average.

Average daily trading volume is 79.50K shares, or about $124,020 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PCSA valuation vs. peer median

PCSA compared with the median of 8 peer companies
MetricPCSAPeer medianDifference
Market cap$4.37M$3.98M+10%
Avg. volume79.50K73.20K+9%

Peer median across 8 companies: CANF, PULM, SCNX, BLRX, LTRN, ALZN, SILO, BGMS.

Valuation

Price and trading

Previous close
1.69
Open
1.64
Day range
1.39 – 1.66
52-week range
1.04 – 8.88
Beta
—
Volume
69.95K

Dividends and events

Annual dividend
None
Next earnings date
Aug 11, 2025

Additional statistics

Market Cap
4.37M
Forward Pe
-0.42
Eps
-68.29
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
8.88
Week52 Low
1.04
Avg Volume
79,500.00
Shares Outstanding
2.80M
Ma50
1.78
Ma200
2.27
Earnings Date
Aug 11, 2025
Pct From52w High
-82.43%
Pct From52w Low
49.86%

Related